Showing results (461-470 of 2,609) with videos related to
Sort By:
Pageof 261
Oncology Research|September 8, 2025
TIMM8A-TIMM13 Complex Exerts Oncogenic Functions in Lung CancerShengmin Li, Kejian Shi, Ying Wang, et al.Oncology Research|September 8, 2025
MYH11 Suppresses Colorectal Cancer Progression by Inhibiting Epithelial-Mesenchymal Transition via ZEB1 RegulationYuhang Jiang, Yijun Xu, Qi Zhu, et al.Oncology Research|September 8, 2025
Advances in Tumor Microenvironment and Immunotherapeutic Strategies for Hepatocellular CarcinomaJiahao Xue, Jingchang Zhang, Gang Chen, et al.Oncology Research|August 1, 2025
Dysregulated PI3K/AKT signaling in oral squamous cell carcinoma: The tumor microenvironment and epigenetic modifiers as key driversVinothkumar Veerasamy, Veeravarmal Veeran, Siddavaram NaginiOncology Research|August 1, 2025
Novel Stemness-Associated Scores: Enhancing Predictions of Hepatocellular Carcinoma Prognosis and Tumor Immune MicroenvironmentGaofeng Pan, Jiali Li, Weijie Sun, et al.Oncology Research|August 1, 2025
3-O-Acetyl-11-Keto-β-Boswellic Acid Suppresses Colitis-Associated Colorectal Cancer by Inhibiting the NF-Kb Signaling Pathway and Remodeling Gut MicrobiotaFang Xu, Wan Li, Xiang-Jin Zheng, et al.Oncology Research|August 1, 2025
Rare Primary Diffuse Large B-Cell Lymphoma Confined to Bone Marrow: Features and PrognosisWeiwei Chen, Xiaodie Zhou, Huiyu Li, et al.Oncology Research|August 1, 2025
USP13 Suppresses Colorectal Cancer Angiogenesis by Downregulating VEGFA Expression through Inhibition of the PTEN-AKT PathwayGuo-Zhi Xu, Han-Yang Guan, Yan-Guan Guo, et al.Oncology Research|June 14, 2020
CD13: A Key Player in Multidrug Resistance in Cancer ChemotherapyQie Guo, Xiao Li, Meng-Na Cui, et al.Oncology Research|July 4, 2025
Immune landscape of neoadjuvant chemoradiotherapy: involvement of MAL, a T-cell differentiation proteinKosei Nakajima, Yoshinori InoPageof 261